New Report from MGA Examines the One-Year Cost Savings Lost Due to Patent Thickets MGA has released a new report today for the Coalition for Affordable Prescription Drugs (CAPD), “Patent Thickets and Lost Drug Savings.” This report, authored by Alex Brill...
Patent Thickets Constrain US Biosimilars Market Alex Brill and Christy Robinson | BioProcess International Biosimilars represent a significant cost-savings opportunity in the United States because they can introduce competition for some of the most expensive and...
